Ongoing Progress of MitraClip(R) Therapy Highlighted at TCT 2009MENLO PARK, California - - European Commercial Pace Continues to Grow with 200 Patients Treated The End of the Sick DayANDOVER, England - Over half of people living in Britain are so scared of losing their job in the current climate that they are risking their health by working through illness. This is according to those surveyed as part of Simplyhealth’s Bothered Britain Report, which is released this month. The report investigates how attitudes and behaviour have changed in the past year towards health-related issues, as well as looking at what people are really bothered about at the moment. Patients Fear Osteoporosis Quality of Life Impact, Yet Lack Tools to Manage Concerns and Improve Osteoporosis Outcomes, New Survey SaysDENVER - - International Osteoporosis Foundation (IOF) launches OsteoLink to address unmet needs in osteoporosis management through digital and in-person patient and physician communication networks across Europe and Australia New Online Resource for People with Parkinson’s, Their Families and CarersFLORENCE, Italy - - Lundbeck and Teva Launch www.myPDinfo.com Lundbeck and Teva today announce the launch of www.myPDinfo.com to provide answers to common questions following a diagnosis of Parkinson’s disease. Designed for people with Parkinson’s, their families and carers, the new site provides information on the disease itself, as well as many aspects of treatment and practical disease management such as medication, surgery, diet, exercise/physiotherapy, and emotional support. 22nd ECNP Congress 2009: The Future of SchizophreniaISTANBUL - At the 22nd Congress of the European College of Neuropsychopharmacology (ECNP), Prof. William Carpenter from the Maryland Psychiatric Research Center, USA, gave today an outlook on a paradigm shift in schizophrenia research, which will have major influence on diagnosis and therapy. “In future schizophrenia research, the focus of therapeutic study will move away from schizophrenia as a disease entity onto specific domains of pathology, promoting the development of targeted drug therapies,” said Carpenter. “This may substantially improve the quality of life for patients in the near future, and prepare the field to address recovery, cure and prevention.” Novant Health Rolls Out MEDai’s Predictive Modeling Solution to Nine Hospitals in Three StatesORLANDO, Florida - - MEDai’s Pinpoint Review Clinical Surveillance System Will Help Novant Hospitals Ensure Patient Safety and Quality, Safeguard Hospital Reimbursement Important Step Forward in Osteoarthritis Research: Bioactive Collagen Peptides Stimulate the Regeneration of Cartilage TissueMONTREAL and KIEL, Germany - Working in collaboration with Kiel University, researchers at the Kiel- based Collagen Research Institute (CRI) have demonstrated the stimulating effect of special bioactive collagen peptides (FORTIGEL(R)) in the context of cell experiments. Last weekend the CRI presented its research findings at the congress of the Osteoarthritis Research Society International (OARSI) in Montreal. The investigations of the CRI provide an explanation for the findings of a joint clinical trial carried out by Harvard Medical School and Tufts Medical Center - likewise presented at the congress. With the aid of special imaging (MRI) techniques this clinical trial demonstrated that FORTIGEL(R) stimulated cell metabolism in the knee-joint cartilage and promotes the regeneration of cartilage tissue. Frost & Sullivan Finds the Untapped Patient Monitoring Solutions Market in Europe Offers Lucrative OpportunitiesLONDON - The market potential for patient monitoring solutions has largely remained untapped, while the demand that potentially exists is significant. Ageing baby boomers and the expansion of the middle class are the main drivers of the European patient monitoring market. Baby boomers are the leading consumers in healthcare by being more involved in the decision-making process on their treatment and overall health management. Moreover, the major impetus for physicians, hospitals and home health organisations to focus on monitoring their patients is cost. Fountain Healthy Aging Inc Announces Agreement to Acquire Natural Planet USALOS ANGELES - Fountain Healthy Aging Inc. announced on September 14 2009 that it had entered into an agreement to acquire the entire issued stock of Natural Planet USA Inc, a California based developer and distributor of a range of specialist nutraceutical and cosmoceutical products both in the US and across a range of international markets. Fountain has had a relationship with Natural Planet for some months, and has sourced a number of its key products from the Natural Planet product pipeline, as well as engaging Natural Planet as a non exclusive distributor of its flagship product, Vitalife, in the US. Dr M Group Selects Health Robotics’ Technology Over RIVA for all of its I.V. Compounding Centers in South East AsiaBOZEN, Italy - Health Robotics today reported that Dr M Group has selected the CytoCare(TM) and i.v.STATION(TM) Robots to be deployed across all of its I.V. Compounding Centers in Malaysia, Singapore, Indonesia, Vietnam, and India. Frost & Sullivan Honours Kemin Health With Global Weight Management Ingredients New Product Innovation AwardLONDON - The 2009 Frost & Sullivan Global Weight Management Ingredients New Product Innovation Award is presented to Kemin Health. Results of RebiSmart(TM) User Trial Presented at 25th ECTRIMS Congress Show Broad Patient Acceptance of the New Electronic Delivery Device for Relapsing Multiple Sclerosis Treatment Rebif(R)GENEVA - - The Majority of Patients Found the Electronic Multidose Device “Suitable” or “Very Suitable” for Self-Injection and Rated the Device Functions as “Easy” or “Very Easy” to Use Size and Growth for Medical Beds and Chairs MarketMedical Beds and Medical Chairs Report ( http://www.bharatbook.com/Market-Research-Reports/Medical-Beds-and-Medical-Chairs.html ) provides the reader with an overview of the medical beds and medical chairs industry and the trends driving growth. Medical beds include all hospital types of beds including mattresses and overlays. The term medical chairs can refer to many different types of chairs including ENT chairs, examination chairs, blood drawing chairs, cardiac chairs, dialysis chairs, ophthalmic chairs, surgery chairs and many more. For the purposes of this report, only rehabilitation chairs and wheelchairs are considered in the market coverage. Amnis advocates a strategic approach to ensuring NHS efficiencyAccording to the specialist healthcare quality, innovation and productivity improvement enabler, Amnis, there needs to be a fundamental shift in the way healthcare organisations work, both internally and across health economies - if the opportunities identified recently for improvements in the efficiency of healthcare are to be realised. New Data From CLARITY Study on Disease Activity in MS Patients who Received Cladribine Tablets Presented at 25th ECTRIMS CongressDÜSSELDORF, Germany and GENEVA - - Post-hoc Analysis From CLARITY Study Show That Short-Course Oral Treatment With Cladribine Tablets Significantly Increased the Proportion of Patients who had Absence of Disease Activity Compared With Placebo ThromboGenics is Shortlisted for “Biotech Company of the Year” and “Licensing Deal of the Year” at Scrip Awards 2009LEUVEN, Belgium - - ThromboGenics’ Significant Achievements Over the Last Year are Recognised in Nominations Life Sciences Vital for Economic RecoveryLONDON - The Association of British Pharmaceutical Industry (ABPI) will be launching their manifesto ‘Prescription for Innovation’ on Monday 14 September at Imperial College. The manifesto will be launched by Chris Brinsmead, President of the ABPI, in partnership with Richard Lambert of the CBI, Professor Steve Smith of Imperial and Ade Adeagbo of patients’ organisation National Voices. New Research Indicates 95% of Patients are in Moderate to Severe Chronic Pain Despite One Year of TreatmentEUROPEAN FEDERATION OF CHAPTERS OF THE INTERNATIONAL ASSOCIATION FOR THE STUDY OF PAIN (EFIC) CONGRESS, LISBON - Milliman Estimates Impact of Swine Flu on Employer Revenue and ProfitsLONDON - Modelling carried out by Milliman actuaries estimates that a severe swine flu pandemic has the potential to reduce a typical UK employer’s revenue by 4%-5% and its profit rate by five to six percentage points during the quarter of the pandemic. arGEN-X Raises EUR9.5 Million to put SIMPLE Antibody(TM) Platform to WorkROTTERDAM, The Netherlands - arGEN-X BV, a biopharmaceutical company focused on the discovery and development of human antibodies using its proprietary SIMPLE Antibody(TM) platform, today announced the successful first closing of its Series A equity financing round. The Company raised EUR 9.5million (~ USD 13.6 million) from a syndicate of leading life science investors. The financing round is one of the largest of its kind in the last 12 months. Pergamum to Provide Effective Development of Innovative Dermatology and Wound Healing CompaniesSTOCKHOLM - Pergamum AB has announced its formation; Pergamum will commercialize the Karolinska Development dermatology and wound healing interests, and create a broad-based therapeutic company in its focus areas. Linda Dyson Joins Cohn & Wolfe as Global Healthcare Practice LeaderNEW YORK - Cohn & Wolfe, a leading global public relations agency, today announced that Linda Dyson has joined the firm as Executive Vice President and Global Healthcare Practice leader. She will report to Donna Imperato, CEO of Cohn & Wolfe. PRA International Chairs Session on Post Marketing Safety IssuesRALEIGH, North Carolina - - PRA Experts Present at the World Drug Safety Congress PRA International, a leading Clinical Research Organization, will chair and present at a session during the Third Annual World Drug Safety Congress to be held in London on 16-17 September, 2009. The Congress is a gathering of leading Safety, Risk Management and Pharmacovigilance professionals. On 16 September, Dr. Sabine Richter, PRA’s Vice President of Safety and Risk Management, will chair a session on Post Marketing Safety Strategy. In this session, Mark Nelson Tyrrell, BS, RPh, Director, Safety and Risk Management at PRA, will present: Post-Marketing Safety Surveillance Design: Choices and Implementation. Helix BioPharma Closes Private PlacementAURORA, Ontario - Helix BioPharma Corp. (TSX, FSE: “HBP”; OTCQX: “HXBPF”) today announced that it has closed its previously announced private placement of 6,625,000 units at US$2.05 per unit. realbuzz.com Top 25 Things to do Before You DieLONDON - Have you ever thought about what you want to do before you die? The 2007 film The Bucket List highlighted this with Jack Nicholson, and Morgan Freeman. With the bucket list being effectively your list of things you want to achieve before you die. So, do you want to Climb a mountain, drive a Ferrari, run a marathon? Or just simply make a million… First Results From Major European Patient Survey Show Devastating Impact of Living With Breakthrough Cancer PainLISBON, Portugal - - Choosing a More Appropriate Route of Administration for Fast Acting Pain Relief Could be the key to Improvement New Chief Executive Officer and Vice President Commercial Operations USA at the Helsinn Group’s American subsidiary, Helsinn Therapeutics (U.S.) Inc.LUGANO, Switzerland - As part of the Helsinn Group’s development strategy, William Mann, PhD, has been appointed as new CEO in the American subsidiary, Helsinn Therapeutics (U.S.) Inc. William Mann, PhD, was already Chief Operating Officer of the recently acquired Helsinn Therapeutics, and has held leadership positions in a Swiss multinational with positions in Business Development and in Research. Clinical Therapeutics Announces the Addition of Michael G. Spigarelli, MD, PhD, as Editor for a Refocused Pediatric, Adolescent, & Maternal Therapeutics SectionBRIDGEWATER, England - Clinical Therapeutics,( www.clinicaltherapeutics.com/) the world’s premier, rapid-publication journal, is proud to announce the addition of Michael G. Spigarelli, MD, PhD, to our distinguished editorial board. 2009 India Excellence in Healthcare AwardsMUMBAI, India - - Annual India Excellence in Healthcare Awards to Celebrate Best in the Industry Relaunched Healthcare Republic Provides the Best Online Resources for Primary Care PractitionersLONDON - Users of leading primary care website Healthcare Republic ( www.healthcarerepublic.com/) will now find it easier than ever to find drug and research updates, archived articles and breaking news from all of Haymarket’s medical publications. VantagePoint Venture Partner’s Portfolio Companies Take Top Rankings in Guardian’s Global CleanTech 100SAN BRUNO, California - - Three Portfolio Companies Included in Top 10, 13 in Top 100 VantagePoint Venture Partners is pleased to announce that a majority of the firm’s clean technology investments have been recognized as leaders by The Guardian, a London-based media group, in its annual 100 Global CleanTech Companies rankings. Karolinska Development Introduces New Concept for Development of its Dermatology and Wound Healing PortfolioSTOCKHOLM - Karolinska Development (publ) have announced the formation of Pergamum AB, a company that will commercialize its dermatology and wound healing opportunities as associated business units within one company. Karolinska Development has transferred all of its holdings from its five dermatology and wound healing companies to Pergamum AB, owning 64% of the new company. Tata Interactive Systems Initiates Vertical-Focused Learning Solutions for Health Care, Pharmaceutical, and BiotechnologyMUMBAI, India - - Tata Interactive Systems Announces its First Domain-Specific Learning and Consulting Solutions for Health Care MitraClip(R) Therapy Introduced in AustriaMENLO PARK, California - - Use of the MitraClip(R) System Continues to Expand in Europe /C O R R E C T I O N — Clinical Therapeutics/BRIDGEWATER, New Jersey - In the news release, “Clinical Therapeutics Announces the Addition of Michael G. Spigarelli, MD, PhD, as Editor for a Refocused Pediatric, Adolescent, & Maternal Therapeutics Section” issued on 9 Sep 2009 08:30 GMT, by Clinical Therapeutics over PR Newswire, we are advised by a representative of the company that the Dateline has been changed from “Bridgewater, England” to “Bridgewater, New Jersey” and the contact number has been changed from +44(0)908-547-2094 to +1-908-547-2094 which were incorrectly transmitted by PR Newswire. Complete, corrected release follows: |
